IFF Announces Sale of Its Pharma Solutions Business to Roquette

IFF (NYSE: IFF) announces that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to $2.85 billion, which represents an enterprise value to EBITDA multiple of approximately 13x. IFF’s Pharma Solutions business is a well-established developer and manufacturer of pharmaceutical excipients and includes its Global Specialty Solutions business supporting industrial and methyl cellulosic food applications. Pharma Solutions operates 10 research and development and/or production sites globally, with approximately 1100 employees, and generated approximately $1B revenue in 2023.

Read the full article: IFF Announces Sale of Its Pharma Solutions Business to Roquette //

Source: https://www.businesswire.com/news/home/20240318143532/en/IFF-Announces-Sale-of-its-Pharma-Solutions-Business-to-Roquette

Leave a Comment

Your email address will not be published.

Scroll to Top